GT Biopharma, Inc.GTBPNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank50
Year-over-Year Change
Year-over-year SG&A expense growth
Latest
4.48%
↓ 98% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
193.01%
Historical baseline
| Period | Value |
|---|---|
| 2025 | 4.48% |
| 2024 | 20.48% |
| 2023 | -42.87% |
| 2022 | -74.03% |
| 2021 | 663.24% |
| 2020 | -35.84% |
| 2019 | -21.63% |
| 2018 | -90.72% |
| 2017 | 1501.40% |
| 2016 | 5.59% |